Stay updated on Organon & Co. Press Releases
Sign up to get notified when there's something new on the Organon & Co. Press Releases page.
Latest updates to the Organon & Co. Press Releases page
- Check4 days agoChange DetectedOrganon has announced positive topline Phase 3 study results for Dysmenorrhea and appointed Daniel Karp as Executive Vice President, Corporate Development, while previous announcements regarding Q1 2024 results and a clinical study have been removed.SummaryDifference71%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedOrganon and Lilly have expanded their migraine commercialization agreement to 11 additional markets, while a previous announcement regarding HADLIMA's selection by the VA has been removed.SummaryDifference11%
- Check26 days agoChange DetectedThe website has added a new section for Cookie Preferences.SummaryDifference0.5%
- Check33 days agoChange DetectedOrganon has reported its second quarter results for June 30, 2024, while a previous announcement regarding U.S. grant programs aimed at reducing unplanned pregnancies has been removed.SummaryDifference72%
- Check47 days agoChange DetectedThe website has added new content, while the 'Cookie Preferences' section has been removed.SummaryDifference0.5%
- Check48 days agoChange DetectedThe website has added a new section for Cookie Preferences.SummaryDifference0.5%
Stay in the know with updates to Organon & Co. Press Releases
Enter your email address, and we'll notify you when there's something new on the Organon & Co. Press Releases page.